Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
- 3 May 2007
- journal article
- Published by Wiley in Transfusion
- Vol. 47 (8), 1436-1446
- https://doi.org/10.1111/j.1537-2995.2007.01220.x
Abstract
BACKGROUND: Human multipotent mesenchymal stromal cells (MSCs) are promising candidates for a growing spectrum of regenerative and immunomodulatory cellular therapies. Translation of auspicious experimental results into clinical applications has been limited by the dependence of MSC propagation from fetal bovine serum (FBS). STUDY DESIGN AND METHODS: The capacity of human platelet lysate (HPL) to replace FBS for clinical-scale MSC propagation was analyzed. RESULTS: HPL could be efficiently produced from buffy coats. Multiplex analyses allowed a distinct HPL growth factor profile to be delineated. With a previously established two-step clinical-scale procedure, HPL was reproducibly more efficient than FBS in supporting MSC outgrowth. With only 3 × 105 primary culture-derived MSCs, a mean of 4.36 × 108 HPL-MSCs (range, 3.01 × 108-5.40 × 108) was obtained within a single secondary 11- to 13-day culture step. Although morphologically distinct, HPL-MSCs and FBS-MSCs did not differ significantly in terms of immunophenotype, differentiation potential in vitro, and lack of tumorigenicity in nude mice in vivo. CONCLUSIONS: Replacing FBS with HPL prevents bovine prion, viral, and zoonose contamination of the stem cell product. This new efficient FBS-free two-step procedure for clinical-scale MSC propagation may represent a major step toward challenging new stem cell therapies.Keywords
This publication has 47 references indexed in Scilit:
- Cell Culture Medium Composition and Translational Adult Bone Marrow‐Derived Stem Cell ResearchThe International Journal of Cell Cloning, 2006
- Enhanced Engraftment of Mesenchymal Stem Cells in a Cutaneous Wound Model by Culture in Allogenic Species‐Specific Serum and Administration in Fibrin ConstructsThe International Journal of Cell Cloning, 2006
- Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formationTransfusion Medicine, 2006
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applicationsJournal of Cellular Physiology, 2005
- Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy PatientsTransplantation and Cellular Therapy, 2005
- Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapyTransfusion, 2005
- Effects of platelet lysates on select bone cell functionsClinical Oral Implants Research, 2004
- Mesenchymal stem cells from cryopreserved human umbilical cord bloodBiochemical and Biophysical Research Communications, 2004
- Autologous platelets as a source of proteins for healing and tissue regenerationThrombosis and Haemostasis, 2004
- Platelets are mitogenic for periosteum‐derived cellsJournal of Orthopaedic Research, 2003